ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

ACR Convergence 2026

November 6-11, 2026. Orlando, Florida.

View by Number View by Title View Sessions
All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 0799
    A Case-Control Study of Immunosuppressive Medication Risk Factors for Developing Pneumocystis jirovecii Pneumonia in Patients With Autoimmune Rheumatic Diseases
  • Abstract Number: 2700
    A CDC WONDER Database Analysis on Trends of SLE Mortality from 1999-2024
  • Abstract Number: 0288
    A Comparative Study of Clinical Manifestations of Yao Syndrome and Systemic Lupus Erythematosus
  • Abstract Number: 1735
    A Comparison of Healthcare Resource Utilization Amongst African American Women with and without Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 0471
    A Comprehensive Risk Score Integrating Genetic, Environmental, and Clinical Factors to Assess Incident Rheumatoid Arthritis Risk
  • Abstract Number: 1869
    A Computer Vision Approach for the Detection of Joint Effusions Using Digital Hand Photographs
  • Abstract Number: 1478
    A Consensus Based Foot and Ankle Examination of the Adult for Rheumatology Training
  • Abstract Number: 2842
    A Cross-Platform Urinary Proteomic Atlas of Disease Activity, Treatment Response, and Kidney Function Loss in Lupus Nephritis
  • Abstract Number: 0669
    A Deep Dive Into Safety: 2.5 Year Follow Up of Chikungunya Virus (CHIKV) Virus-Like Particle (VLP) Vaccine
  • Abstract Number: 2129
    A deep learning model predicting the survival of Anti-neutrophil cytoplasmic antibody -associated vasculitis
  • Abstract Number: 1894
    A Distinctive Serum Proteomic Signature of Ocular Ischemia in Giant Cell Arteritis Showing Attenuated Circulating Adaptive Immunity and an IL-33/ST2 Innate-Tissue Axis
  • Abstract Number: 2066
    A Genome-Scale, In Vivo Transcription Factor Screen Identifies a Previously Unrecognized Factor That Enhances CAR-T Persistence and Tumor Control Under High-Dose Rechallenge
  • Abstract Number: 1770
    A Hard Pill to Swallow: A Lupus Nephritis Medication Adherence Pilot Using Proactive Screening and Clinical Pharmacy Intervention
  • Abstract Number: 2042
    A Homozygous IRAK2 Q127H Variant Drives Exaggerated Innate and Interferon Signaling in IFN-high Still’s Disease
  • Abstract Number: 1035
    A Human Joint-on-a-Chip Platform Reveals Anti-inflammatory Effects of Cytokine-Rich Autologous Serum Derived from Patients with Rheumatoid Arthritis
  • Abstract Number: 0779
    A Large Language Model Framework for Advancing Evidence-Based Rheumatology Care: Integration of Biomedical Literature and Pharmacovigilance Data
  • Abstract Number: 1929
    A lupus nephritis endotype is driven by gut microbial lipoglycan through TLR2-independent, lectin receptor-mediated immune activation
  • Abstract Number: 0289
    A Machine Learning-Based Model Outperforms Eleven Conventional and Disease-Adapted Scores in Predicting 10-Year Cardiovascular Events and Atherosclerotic Plaque Progression in Systemic Lupus Erythematosus
  • Abstract Number: 1684
    A Machine Learning-Driven Approach to Non-invasive Microvascular Phenotyping in Arthritis
  • Abstract Number: 0955
    A model to predict high-resolution manometry abnormalities in systemic sclerosis created using unbiased machine learning of chest computed tomography-derived esophageal parameters: a pilot study
  • Abstract Number: 2382
    A Molecular Treatment Response Signature Improves Efficacy of T-Cell Therapy in Rheumatoid Arthritis
  • Abstract Number: 1491
    A Multi-Method Approach to Characterizing the Family Experience of the Diagnostic Process for Juvenile Idiopathic Arthritis
  • Abstract Number: 0376
    A Multi-Peptide Anti-14-3-3eta Autoantibody Model Differentiates Radiographic and Non-Radiographic Axial Spondyloarthritis
  • Abstract Number: 1644
    A Multicenter, Randomized, Double-Blind, Placebo/Febuxostat-Controlled, Phase 2b/3 Study to Assess the Efficacy and Safety of ABP-671 in Participants With Gout and Hyperuricemia: Results from the 24-Week Extension Period of the Phase 2b Study
  • Abstract Number: 0590
    A Multicomponent Shared Decision-Making Intervention Improves Adherence in Rheumatoid Arthritis
  • Abstract Number: 1875
    A Multimodal Intervention Improves the Collection of Disease Activity Measures in a Multi-Centered National Rheumatoid Arthritis Network
  • Abstract Number: 0748
    A Multimodal Optimal Biomarker Approach to Characterize Multicenter Patients with Retroperitoneal Fibrosis (RPF)
  • Abstract Number: 2839
    A New Endpoint for SLE Clinical Trials: The Treatment Response Measure for Systemic Lupus Erythematosus Clinical Trials (TRM-SLE)
  • Abstract Number: 0800
    A New Genetic Determinant Of Spondyloarthritis: HLA-B*51 Allele In A Southern European Population
  • Abstract Number: 0801
    A New ICD-10 Code Opens a Real-World Window on IgG4-Related Disease: Propensity-Matched Outcomes of Rituximab Versus Conventional Immunosuppression, With an Early Look at Inebilizumab
  • Abstract Number: 1940
    A new mammalian model of Deficiency of Adenosine Deaminase 2 (DADA2) disease
  • Abstract Number: 1036
    A Novel Anti-TNFα/OX40L Bispecific Antibody Breaks the Innate-Adaptive Immunity Loop for Potential Remission in Rheumatoid Arthritis therapies
  • Abstract Number: 0995
    A Novel APRIL/BAFF Dual-Target Humanized Mouse Model of SLE for Preclinical Evaluation of Therapeutics Targeting APRIL/BAFF
  • Abstract Number: 0632
    A Novel Bone Histopathology Scoring System Identifies Fibro-myxoid Bone Marrow Changes Associated with Pain in Knee Osteoarthritis
  • Abstract Number: 0022
    A Novel HDAC6 Deacetylase Inhibitor Elongates Primary Cilia in Fibroblasts: Ciliotherapy for Fibrosis
  • Abstract Number: 2582
    A Novel Longitudinal Protocol for Monitoring Calcinosis in Juvenile Dermatomyositis: Serial Ultra-Low-Dose Whole-Body CT
  • Abstract Number: 2067
    A Novel Negative-Pressure Blind Synovial Biopsy Needle in 932 Patients: Diagnostic Spectrum, Tissue Quality, Molecular Compatibility, and Safety
  • Abstract Number: 2855
    A Novel TLR7 Gain-of-Function Variant Broadens RNA Ligand Specificity to Drive Lupus in Human and Mice
  • Abstract Number: 1557
    A novel, pragmatic frailty measure predicts bone mineral density declines better than a traditional frailty measure in Rheumatoid Arthritis
  • Abstract Number: 1099
    A novel, recycling anti-TL1A x IL23 bispecific antibody with extended half-life for the treatment of inflammatory bowel disease
  • Abstract Number: 0965
    A Pan Gamma-Delta (γδ) T cell Engager to Induce In Vivo Expansion of γδ T cells for Deep B cell Depletion in Autoimmune Diseases
  • Abstract Number: 1086
    A Pan-Autoimmune Tissue Transcriptomic Atlas Reveals Distinct Baseline Architectures and Disease-Associated Immune Shifts Across Immune-Mediated Inflammatory Diseases
  • Abstract Number: 2810
    A Pathogenic Myositis-Specific Autoantibody-NETosis-Calprotectin Axis Drives Calcinosis in Juvenile Dermatomyositis
  • Abstract Number: 2483
    A patient-centered prioritized outcome measure for N-of-1 trials in Childhood Sjögren’s Disease
  • Abstract Number: 2519
    A Patient-Informed, Novel Community Portal within the Lupus Nexus
  • Abstract Number: 0344
    A Phase 4, Prospective, Open-Label Study to Assess the Effectiveness of Adding Tirzepatide After Initiation of Ixekizumab in Adults With Psoriatic Arthritis and Overweight or Obesity
  • Abstract Number: 0834
    A Pilot Multidisciplinary Lupus Nephritis Clinic Addresses Social Determinants of Health and Improves Access to Multitarget and Investigational Therapies
  • Abstract Number: 1070
    A Pilot Safety Study of an Intra-articular Administration of a Neutralizing Anti-CD14 Antibody In a Yucatan-Minipig PTOA Model
  • Abstract Number: 1795
    A Pilot Trial of Computerized Action Planning for Physical Activity in Employees with Knee Symptoms
  • Abstract Number: 0117
    A Population of CD57⁺ CD8⁺ T Cells With Cytotoxic Potential Are Expanded in Immune-Mediated Necrotizing Myopathy and Dermatomyositis
  • Abstract Number: 1582
    A practical CK-based framework for interpreting transaminase elevations in idiopathic inflammatory myopathies
  • Abstract Number: 2413
    A Pragmatic Phenotype-Based Score for Identifying Subclinical Multi-Territory Atherosclerosis in Rheumatoid Arthritis (RADAR-4)
  • Abstract Number: 0555
    A Preliminary Exploration of the Relationship between Depression, Anxiety, Patient-Reported Outcomes and Disease Characteristics in Youth with Juvenile Dermatomyositis
  • Abstract Number: 1977
    A Pro-Migratory Paradox: Methylprednisolone Dampens Cytokine Secretion yet Enhances Neutrophil Migration in Health and Systemic Lupus Erythematosus
  • Abstract Number: 2152
    A Prospective Randomized Trial of Stem Cell Enriched Autologous Lipotransfer for Orofacial Fibrosis in Systemic Sclerosis (Sys-Stem)
  • Abstract Number: 0512
    A Prospective, Real-World Registry for Systemic Lupus Erythematosus: The PPD CorEvitas SLE Registry
  • Abstract Number: 0513
    A qualitative assessment of patient- and physician-perceived barriers and facilitators to participation in synovial biopsy research
  • Abstract Number: 0835
    A Quality Improvement Project to Evaluate and Improve Laboratory Monitoring Frequency in Patients with Rheumatologic Diseases on Methotrexate.
  • Abstract Number: 2383
    A randomized, double-blind, multicenter study to compare the immunogenicity and safety of proposed abatacept biosimilar (DRL_AB) with Orencia® administered subcutaneously as an add-on to methotrexate in patients with moderately to severely active rheumatoid arthritis (RA)
  • Abstract Number: 2907
    A Re-Analysis of the RECONNOITER Phase 2 Trial of AISA-021 in the Treatment of Raynaud’s Phenomenon Associated with Systemic Sclerosis – The Effects of Non-Specific Symptoms on Endpoints in Studies of Raynaud’s Therapies
  • Abstract Number: 1671
    A Real World Analysis of Patients with Rheumatoid Arthritis on Immune Checkpoint Inhibitor Therapy for Cancer : Results from the IMPACT-MB Database
  • Abstract Number: 0670
    A Retrospective Study Comparing the Efficacy and Safety of Biosimilar and Originator TNF-alpha Inhibitors in Cardiac Sarcoidosis
  • Abstract Number: 1050
    A Rheumatoid Arthritis (RA)-Specific Rheumatoid Factor in Anti-CCP(+) Pre-RA Individuals is Associated with Future Development of RA
  • Abstract Number: 2068
    A RUNX1-Bound Enhancer Variant at IRF8 Amplifies cGAS-STING-Induced Type I Interferon Responses in SLE Monocytes
  • Abstract Number: 1479
    A Scoping Review on Gout Education for Primary Care Clinicians
  • Abstract Number: 0001
    A Single-Cell and Spatial Transcriptomic Atlas of the Inflamed Aorta: Decoding the Pathogenesis of Clinically Isolated Aortitis
  • Abstract Number: 0039
    A single-cell atlas of >1 million blood and lymph node immune cells reveals peripheral and tissue immune reprogramming following CD3×CD19 T-cell engager therapy in active SLE
  • Abstract Number: 0633
    A Staged Detection Pipeline for Mechanically Meaningful Events in Knee Acoustic Emissions: Promiscuous Candidate Ensembles for Combinatorial Refinement
  • Abstract Number: 0780
    A Survey Investigation of Multidisciplinary Rheumatology-Dermatology Clinics in the U.S.
  • Abstract Number: 0671
    A Ten-Year Descriptive Study of IgG4-Related Disease at a Tertiary Care Center in New York City
  • Abstract Number: 0886
    A Trans-Dominant Negative MiT/TFE Transcription Factor Selectively Marks Pathogenic B Cells in Lupus
  • Abstract Number: 0937
    A TREM2-anchored macrophage program in antiphospholipid syndrome skin links lipid handling to microvascular disease
  • Abstract Number: 0472
    A Two-Stage Multimodal Fusion Framework for Automated Diagnosis of Inflammatory Arthritis: From Inflamed Joints Detection to Subtype Differentiation
  • Abstract Number: 0781
    A video-based training protocol for patient-led joint examination demonstrates strong concordance with rheumatologist-assessed disease activity in rheumatoid arthritis: A pilot study
  • Abstract Number: 2414
    A Vision Transformer-based transfer learning approach to infer Metacarpophalangeal joint swelling from hand photographs in Rheumatoid Arthritis
  • Abstract Number: 2384
    AB-101, Outpatient-Administered, Non-Genetically Modified NK Cells in Combination with Rituximab, Demonstrates Favorable Safety Profile in a Large Cohort of 60 Patients with Rheumatological Diseases while Consistently Achieving Deep B-cell Depletion
  • Abstract Number: 1899
    AB-101, Outpatient-Administered, Non-Genetically Modified NK Cells, in Combination with Rituximab Generate Robust Efficacy Responses Comparable with Autologous CAR T in 34 Patients with Rheumatologic Diseases
  • Abstract Number: 2549
    Abdominal Aortic Calcification Is Associated With Higher Fracture Risk Despite Preserved Lumbar Bone Density in Postmenopausal Women
  • Abstract Number: 0977
    Aberrant B Cell Transcriptomic Signatures Are Already Present in Pre-Clinical Systemic Sclerosis, as Revealed by Single-Cell Profiling
  • Abstract Number: 1172
    ABO2203, an mRNA-Encoded CD3×CD19 T-Cell Engager (TCE), Mediates Deep B-Cell Depletion and Clinical Improvement in Systemic Sclerosis (SSc): First-in-Human Results
  • Abstract Number: 2164
    Absence of risk factors does not rule out SSc-ILD: mandatory HRCT screening and superior detection with lung volumes over spirometry
  • Abstract Number: 1076
    Absence of Viral Signatures in Muscle Biopsies from Patients with Idiopathic Inflammatory Myopathies
  • Abstract Number: 2950
    Accelerated but miscalibrated: a randomized controlled trial of medically certified LLM-assisted diagnostic support in rheumatology
  • Abstract Number: 0159
    Accelerated Coronary Artery Aneurysm Remodeling Following Etanercept Rescue Therapy in Kawasaki Disease: A Four-Patients Case Series
  • Abstract Number: 2228
    Accelerated Organ Damage Accrual After Initial Damage in Systemic Lupus Erythematosus: A Single-Center Cohort Study
  • Abstract Number: 1468
    Accelerated villous maturation and villous infarction distinguish placentas of small for gestational age infants in systemic lupus erythematosus
  • Abstract Number: 2471
    Acceptability of Audience-Led Debate for Rheumatology Continuing Medical Education
  • Abstract Number: 1583
    Achievement and Predictors of Glucocorticoid-Free Remission in Anti-MDA5 Antibody-Positive Dermatomyositis: A Single-Center Retrospective Cohort Including 18 Glucocorticoid-Free Cases
  • Abstract Number: 1301
    Achievement of DAPSA/cDAPSA Low Disease Activity With Guselkumab in Active and Erosive Psoriatic Arthritis Across Participant Subgroups in APEX
  • Abstract Number: 0907
    Achievement of Low Disease Activity and Remission in Dermatomyositis Patients Treated with Brepocitinib: Analyses from the Phase 3 VALOR Trial
  • Abstract Number: 0707
    Achievement of Remission in Trial Participants with Gout Initiating Treat-to-Target Urate-Lowering Therapy: Post-hoc Results of the STOP Gout Study
  • Abstract Number: 1116
    Achievement of Sustained Low-Dose Glucocorticoids in Patients With Large-Vessel Vasculitis: A Retrospective Cohort Study Using a Japanese Claims Database
  • Abstract Number: 0556
    Achieving Minimal Disease Activity in Pediatric Chronic Nonbacterial Osteomyelitis: A Comparative Study of Treatment Regimens
  • Abstract Number: 0345
    Achieving Remission or Very Low Disease Activity with Bimekizumab Resulted in Minimal Radiographic Progression up to 3 Years in Biological DMARD-Naïve Patients with Psoriatic Arthritis
  • Abstract Number: 1771
    Acidic Oral Microenvironment Is Independently Associated with Severe Periodontal Disease in Patients with Rheumatic Diseases
  • Abstract Number: 0409
    Acinar Atrophy, Fibrosis, and Salivary Dysfunction in Sjögren’s Disease
  • Abstract Number: 2351
    Acinar Immune Infiltration Distinguishes Sjögren’s Disease From ANA-Positive Sicca Beyond Focus Score ?
  • Abstract Number: 0938
    ACPA-expressing B Cells Cross-present Citrullinated Proteins to Activate Cytotoxic CD8 T Cells in Rheumatoid Arthritis
  • Abstract Number: 0672
    Active Cardiac Sarcoidosis Resolution Without Steroids: Retrospective Single-Center Analysis
  • Abstract Number: 0802
    Active tuberculosis in systemic autoimmune diseases: an epidemiological analysis of a nationwide register-based cohort
  • Abstract Number: 1014
    Activity-Dependent Atherogenic Remodeling in Systemic Lupus Erythematosus Revealed by Integrated Transcriptomics and Proteomics
  • Abstract Number: 1715
    Acute Adrenal Crisis in Autoimmune Rheumatic Disease Patients Receiving Chronic Corticosteroids: A National Inpatient Study
  • Abstract Number: 0514
    ADAM17-mediated soluble PD-1 production indicates immunogenic inflammation
  • Abstract Number: 0346
    Add-on Tirzepatide therapy leads to Improvements in Pain and Clinical Outcomes in Patients with Obesity and Psoriatic Disease and in Patients with Obesity and Non-Inflammatory Arthralgia: Interim Results from a Prospective Cohort Study
  • Abstract Number: 1397
    Adding a Structured Self-Management Program to a Treat-to-Target Strategy in Rheumatoid Arthritis: A Pilot Randomized Controlled Trial
  • Abstract Number: 1398
    Adding Metformin to First-Line Methotrexate in Methotrexate-Naive Patients with Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
  • Abstract Number: 2561
    Adding Tranexamic Acid to Hyaluronic Acid Improves Outcomes in Knee Osteoarthritis: Results from a Randomized Multicenter Trial
  • Abstract Number: 2472
    Addressing Inequities in Lupus Nephritis Care Through Targeted Continuing Education
  • Abstract Number: 1910
    Addressing Social Risk Factors to Improve Care Use Among Patients with Rheumatic Conditions: Results from an Adaptive Randomized Controlled Trial
  • Abstract Number: 1700
    Addressing Structural Inequity in Rheumatology Research: Launch of the Surveillance and Network Database Caribbean Registry with Pragmatic Core Measures
  • Abstract Number: 0541
    Addressing the Scleroderma Education Gap: Patient‑as‑Educator Models for Interprofessional Training
  • Abstract Number: 2484
    Addressing Unmet Needs in Childhood-onset Systemic Lupus Erythematosus Using the Childhood Arthritis and Rheumatology Research Alliance Registry
  • Abstract Number: 2643
    Adjunctive Use of Weakly Alkaline Spring Water (pH 7.8-8.3) in Primary Gout: A Randomized, Single-Blind, Parallel-Group Trial
  • Abstract Number: 1918
    Advancing B-Cell Monitoring In B-Cell-Depleting Therapies For Autoimmune Disorders: Toward Deeper, Broader, And Standardized Assessment
  • Abstract Number: 1685
    Adverse Body Fat Distribution and Poor Muscle Quality in Rheumatoid Arthritis: Insights from a Large CT-Based Study
  • Abstract Number: 1672
    Adverse Drug Events Across Autoimmune Rheumatic Diseases: A Nested, Encounter-Matched Case-Control Study
  • Abstract Number: 1149
    Adverse Events Associated With the Use of Glucocorticoids in Patients With Eosinophilic Granulomatosis With Polyangiitis
  • Abstract Number: 1469
    Adverse Pregnancy Outcomes in Rhupus Syndrome: a Matched Cohort Study
  • Abstract Number: 1844
    Adverse Pregnancy Outcomes in the Lupus in prEGnAnCY (LEGACY) Cohort: Anti-phosphatidylserine/prothrombin IgG Antibodies are Stronger Predictors than Lupus Anticoagulant
  • Abstract Number: 2079
    ADX-001, A Novel Hypoimmunogenic, Half-life Extended Anti-TNFα/IL-23p19 Bispecific Antibody for Inflammatory Disease
  • Abstract Number: 0079
    Afimetoran, an Oral Equipotent Dual Antagonist of Toll-Like Receptor 7 (TLR7) and TLR8, in Combination with an Anti-TNF Results in Increased Efficacy in a Collagen-Induced Arthritis Model
  • Abstract Number: 1245
    Age at Onset and Its Association with Damage Accrual in Systemic Lupus Erythematosus (SLE): Insights from 5 Registries in the Lupus Federated Data Network (LupusNet)
  • Abstract Number: 0473
    Age Explains differences in Survival between RA and non-RA patients with Melanoma treated with Immune Checkpoint Inhibitors
  • Abstract Number: 1117
    Age related differences between children and older teenagers with Takayasu arteritis
  • Abstract Number: 0884
    Age-Associated B cells Exacerbate Primary Sjögren Disease by Promoting Follicular T Helper Cell Differentiation Through PD-L1
  • Abstract Number: 0002
    Age-Related Antigen Discovery in Giant Cell Arteritis
  • Abstract Number: 0613
    Age-related Differences in Patterns of Cannabis Consumption and Subjective Effects in Rheumatic and Musculoskeletal Diseases
  • Abstract Number: 0192
    Age-Related Differences in Treatment Patterns and Mortality Among Patients With ANCA-Associated Vasculitis
  • Abstract Number: 0160
    Age-Stratified Prevalence of Dementia in Giant Cell Arteritis Patients: A Single Center Retrospective Cohort Study
  • Abstract Number: 1427
    Agentic Artificial Intelligence Framework for Longitudinal Rheumatoid Arthritis Ascertainment
  • Abstract Number: 1673
    Aggregate Safety Profile of Rese-cel (Resecabtagene Autoleucel) in Patients with Refractory Autoimmune Diseases
  • Abstract Number: 0803
    Aging Arteries, Changing Care Settings: U.S. Giant Cell Arteritis Mortality, 1999-2020
  • Abstract Number: 2315
    Agreement between ASAS and revised ASAS-SPARTAN classification criteria in axial spondyloarthritis
  • Abstract Number: 1686
    Agreement Between Commercial Artificial Intelligence and Expert Capillaroscopist in Nailfold Capillary Density Assessment: A Two-Center Validation Study
  • Abstract Number: 1716
    Agreement Between Fluorescence Intensity and Endpoint Dilution Titer of Antinuclear Antibodies by Indirect Immunofluorescence
  • Abstract Number: 2415
    Agreement between nurse- and patient-evaluated joint counts in women with rheumatoid arthritis during and after pregnancy
  • Abstract Number: 2686
    AI Triage for Rheumatoid Arthritis Imaging: An Explainable Human-in-the-Loop Framework for Automated Wrist Bone Segmentation and Erosion Assessment
  • Abstract Number: 2583
    AI-Assisted Analysis of IBM Mortality and Cause-of-Death Adjudication in U.S. Veterans: Expert Delphi Consensus vs Large Language Models
  • Abstract Number: 0515
    AI-assisted Screening: Evaluating ASReview for Systematic Literature Reviews for the Development of Rheumatology Recommendations
  • Abstract Number: 0749
    AI-Based Coronary CTA Plaque Analysis Detects Subclinical Atherosclerosis Beyond Coronary Artery Calcium in SLE and RA
  • Abstract Number: 2165
    AI-derived facial motility improvement after prostanoid therapy as a digital marker of microvascular and functional burden in systemic sclerosis
  • Abstract Number: 0966
    AI-Enabled Discovery of Small-Molecule Inhibitors Targeting the TNF Superfamily
  • Abstract Number: 0093
    AI-Enabled Virtual Spatial Proteomics from Routine Histology in Early Rheumatoid Arthritis Synovium
  • Abstract Number: 1480
    AI-Infused Journal Club for Advanced Trainees in Medical Education
  • Abstract Number: 1071
    AIM2 Inflammasome-Mediated Chondrocyte Pyroptosis in Knee Osteoarthritis and the Intervention of Wangbi Formula Combined with Diacerein
  • Abstract Number: 0967
    Aiolos restrains pathogenic CD8⁺ T-Cell Responses in antigen-Induced arthritis
  • Abstract Number: 2859
    Air Pollution Exposure is Associated with Higher Disease Activity in Inflammatory Arthritis
  • Abstract Number: 1645
    Airborne-derived particulate matter enhances with monosodium urate crystals both the secretion of IL-1b by human immune cells and footpad swelling in mice
  • Abstract Number: 2316
    Alignment Between Physician Global Assessment, Composite Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis
  • Abstract Number: 2796
    Allogeneic Dual-Target CD19/BCMA CAR-T Cell Therapy (QT-019B) Induces Deep Immune Reset in Refractory Connective Tissue Disease-Associated Immune Thrombocytopenia
  • Abstract Number: 1978
    Allogeneic HSC-derived CD19 CAR-NK cells mediate potent and selective depletion of B cells from patients with systemic lupus erythematosus
  • Abstract Number: 1332
    Altered Brain Connectivity is Associated with Pain and Disease Burden in Axial Spondyloarthritis
  • Abstract Number: 0069
    Altered circulating B-cell subsets in axial spondyloarthritis and their association with anti-TNF treatment response
  • Abstract Number: 0142
    Altered Peripheral Blood B Cell Populations in Ro Seropositive and Ro Seronegative Sjögren’s Disease Correlate with Clinical Features and Suggest Defective B Cell Tolerance
  • Abstract Number: 1979
    Altered Quinolinic Acid to Kynurenic Acid Ratios Are Associated with Indoleamine 2,3-Dioxygenase Pathway Activation in Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 1960
    Amplification of the Th17/IL-17 Pathway Activation Marks the Transition from Very Early Systemic Sclerosis (VEDOSS) to Established Systemic Sclerosis: A Multi-Omics Analysis
  • Abstract Number: 2606
    Amyloid Storm Across Diverse AA Amyloidosis Etiologies: Clinical Characteristics, Management and Outcomes in a 19-Patient Cohort
  • Abstract Number: 1961
    An Atlas-Guided AI Framework for Cell-Level Profiling of Systemic Sclerosis and Related Skin Diseases
  • Abstract Number: 1980
    An evolution-shaped IKZF1 enhancer switch amplifies type I interferon, and lineage-specific functional-SNP PRS panels stratify lupus nephritis
  • Abstract Number: 0009
    An Ex-Vivo Functional Immune Assay Predicts TNF Inhibitor Response Across T Cell-Mediated Autoimmune Diseases
  • Abstract Number: 2080
    An Fc-Free CD40L-Targeting Tn3 Scaffold (Dazodalibep) Demonstrates Absence of Platelet Activation and Thrombotic Risk Across Preclinical Models
  • Abstract Number: 2043
    An Immune Cell-Skeletal Muscle Microphysiological System to Model the Response to Prednisolone in Juvenile Dermatomyositis
  • Abstract Number: 2961
    An Inelastic Compression Garment Reduces Swelling after Total Knee Arthroplasty: a Prospective Randomized Trial
  • Abstract Number: 1962
    An Integrated Multi-Agent System for Accelerating Rheumatology Research
  • Abstract Number: 1087
    An integrated statistical and deep learning case-control strategy to define rheumatoid arthritis features in H&E whole slide images
  • Abstract Number: 2834
    An Interferon-Independent Stromal-Humoral Niche Persists Following Anifrolumab Therapy in Cutaneous Lupus Erythematosus
  • Abstract Number: 2473
    An Introductory Framework for Longitudinal Musculoskeletal Ultrasound Training in Internal Medicine Residency
  • Abstract Number: 0542
    An Ultrasound-Guided Injection Training Phantom With Integrated Feedback: Development and Multi-Institutional Validation
  • Abstract Number: 2130
    Analytical Evaluation of a Fully Automated Multiplexed Microarray Immunoassay for Detection of Anti-PR3, Anti-MPO, and Anti-GBM Autoantibodies Compared with Routine Immunoassays in Two Clinical Laboratories in the Netherlands
  • Abstract Number: 1333
    Anatomical Distribution and Longitudinal Decline of MRI Lesions Distinguish Early Axial Spondyloarthritis from Chronic Back Pain
  • Abstract Number: 1088
    ANCoR Enables Modality Agnostic, Nuclei-Anchored Registration of Spatial Multi-Omics
  • Abstract Number: 0474
    Angina Pectoris Is More Frequent in Rheumatoid Arthritis and Predicts Mortality to a Similar Extent as in the General Population
  • Abstract Number: 0253
    Anifrolumab in Systemic Lupus Erythematosus with severe hematologic manifestations: an international multicentre study
  • Abstract Number: 1246
    Anifrolumab Treatment is Associated With DORIS-0 Remission in Adults With Systemic Lupus Erythematosus: Real-World Outcomes From an Academic Lupus Registry
  • Abstract Number: 1247
    Anifrolumab Treatment is Associated With Lupus Low Disease Activity State in Adults With Systemic Lupus Erythematosus: Real-World Outcomes From an Academic Lupus Registry
  • Abstract Number: 2192
    Anifrolumab Treatment Prevents Long-Term Oral Corticosteroid-Related, Ocular, and Musculoskeletal Organ Damage Accrual Compared With Real-World Standard of Care in Patients With Systemic Lupus Erythematosus: Findings From the LASER Study
  • Abstract Number: 2193
    Anifrolumab versus Belimumab for Cardiovascular Disease Risk in Systemic Lupus Erythematosus
  • Abstract Number: 2229
    Annual, 5 and 10-Year Direct and Indirect Costs Associated with Damage Accrual: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
  • Abstract Number: 0254
    Anti Rituximab Antibodies and Treatment Failure in Pediatric Systemic Lupus Erythematosus: A Single-Center Case Series
  • Abstract Number: 0377
    Anti-14-3-3eta Autoantibodies Support Differential Diagnosis of Axial Spondyloarthritis (axSpA) from Mechanical and Non-AxSpA Back Pain
  • Abstract Number: 0378
    Anti-14-3-3eta Multiplex Autoantibody Assay Differentiating Axial Spondyloarthritis from Clinically Overlapping Conditions
  • Abstract Number: 1248
    Anti-C1q and Anti-dsDNA Antibodies Centrally Assessed Predict Renal Involvement in SLE Patients from the GLADEL 2.0 Cohort
  • Abstract Number: 2850
    Anti-CD19 CAR T – cell therapy for the treatment of severe/refractory pediatric autoimmune diseases: a single-center case series
  • Abstract Number: 0023
    Anti-CD206 CAR T Cell Immunotherapy Ameliorates Fibrosis
  • Abstract Number: 2284
    Anti-drug antibodies to a first TNF inhibitor predict response to a subsequent biologic in axial spondyloarthritis: data from the ROC-SpA cohort
  • Abstract Number: 0996
    Anti-histone IgM antibodies and NETs define distinct thrombotic risk patterns in systemic lupus erythematosus
  • Abstract Number: 0646
    Anti-HMGCR Immune-mediated Necrotizing Myopathy Shows Robust Treatment Response With Early Rituximab Initiation
  • Abstract Number: 0647
    Anti-MDA5 Dermatomyositis: Long-Term Outcomes from a Single-Centre Cohort with a Focus on Cutaneous Phenotyping
  • Abstract Number: 2584
    Anti-Mi-2-positive interstitial lung disease: a distinct clinical subgroup?
  • Abstract Number: 2932
    Anti-mitofusin-1 autoantibodies are associated with erosive disease in seronegative rheumatoid arthritis: data from the ESPOIR cohort
  • Abstract Number: 0290
    Anti-Nucleosome Antibodies are associated with Early Damage Accrual in Systemic Lupus Erythematosus: a retrospective Cohort Study
  • Abstract Number: 1428
    Anti-PAD4 Antibodies in Seronegative Rheumatoid Arthritis: Real-World Reclassification and Isotype-Specific RA Discrimination
  • Abstract Number: 1250
    Anti-ribosomal p antibodies in systemic lupus erythematosus are not associated with neurological manifestations: a cross-sectional cohort study
  • Abstract Number: 1037
    Anti-TL1A and anti-TNF Show Comparable Efficacy in a Mouse CIA Model Using Transgenic Mice Expressing Human TL1A
  • Abstract Number: 0870
    Anti-Topoisomerase-1 Autoantibodies Exert Intranuclear Pathogenic Activity in Systemic Sclerosis Through FcRn-Dependent Trafficking
  • Abstract Number: 0859
    Anti-β2-Glycoprotein I Antibodies are Frequent in Membranous Lupus Nephritis and are Associated with Renal Non-response in an International Cohort Without Prior Antiphospholipid Syndrome
  • Abstract Number: 2352
    Antibody testing and positivity rates among patients with Sjögren’s disease: A retrospective study from a national reference laboratory
  • Abstract Number: 1027
    Antigen-specific CD8+ T cells with a public TCR clonotype span naive-to-effector states in HLA-B27+ axSpA indicating ongoing replenishment of the pathogenic T cell pool
  • Abstract Number: 1249
    Antimalarial Exposure and Renal Histopathologic Findings in Lupus Nephritis
  • Abstract Number: 2230
    Antiphospholipid Antibodies and Subclinical Carotid Atherosclerosis in systemic lupus erythematosus: A Dose‑Response Association with IgM Isotype Prominence
  • Abstract Number: 2231
    Antiphospholipid Antibody Burden and High-Risk Profiles Are Associated With Adverse Renal Events in Biopsy-Proven Lupus Nephritis: A Multicenter Retrospective Cohort Study
  • Abstract Number: 2096
    Antiplatelet Therapy to Prevent Ischemic Outcomes in Patients with Giant Cell Arteritis: A Systematic Review
  • Abstract Number: 1772
    Antisynthetase Syndrome: Predictors of Poor Outcome
  • Abstract Number: 1948
    ANV200, an Fc-engineered anti-PD-1 antibody that selectively and deeply depletes PD-1 expressing T cells for the treatment of autoimmune diseases
  • Abstract Number: 0924
    Anxiety Is the Strongest Potentially Modifiable Predictor of Longitudinal Cognitive Performance in Systemic Lupus Erythematosus
  • Abstract Number: 0379
    Anxiety, Depression, and Fibromyalgia Compromise Target Attainment in Axial Spondyloarthritis Regardless of Inflammatory Activity
  • Abstract Number: 1606
    Aortic Aneurysms In Patients With And Without Giant Cell Arteritis. A Clinical And Histopathological Study
  • Abstract Number: 1558
    Appendicular Lean Mass is More Consistently Associated than Fat Mass with High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT)-derived Bone Microarchitecture and Estimated Bone Strength in Healthy Women Across Adult Life
  • Abstract Number: 1873
    Applicability of OMERACT salivary gland ultrasound scoring systems in juvenile Sjögren’s disease: a pilot multicenter study
  • Abstract Number: 1100
    Application of a Human Immune System-Reconstituted Mouse Model of Lupus in Evaluating the Efficacy of B Cell-Targeting Therapies
  • Abstract Number: 2797
    aPS/PT Antibody Prevalence in Reproductive-Aged Women at Elevated Risk for Antiphospholipid Syndrome: A Descriptive Study
  • Abstract Number: 1570
    Are discordant grades of effusion-synovitis in knee osteoarthritis associated with differential pain reporting between an individual’s two knees?
  • Abstract Number: 1548
    Are Lupus Education Materials Readable? A Multi-Index Readability Analysis of SLE Patient Resources
  • Abstract Number: 1796
    Are Modifiable Lifestyle Behaviors Associated with Baseline Pain Interference and Physical Function in a Behavioral Intervention Trial for Systemic Lupus Erythematosus?
  • Abstract Number: 1209
    Are RAS Inhibitors Necessary During Intensive Immunosuppression for Lupus Nephritis? Real-World Evidence from the STAR Cohort
  • Abstract Number: 1549
    Are You Tired? Treating Fatigue Using Pain Neuroscience Education
  • Abstract Number: 0094
    Arginase 1-Driven Arginine Metabolism Boosts Th17 Cell Responses to Exacerbate Rheumatoid Arthritis
  • Abstract Number: 2166
    Arrhythmia-Related Outcomes in Diffuse Cutaneous Versus Limited Cutaneous Systemic Sclerosis: A Propensity-Matched Retrospective Analysis
  • Abstract Number: 2798
    Articular Involvement in Antiphospholipid Syndrome: Clinical, Laboratory, and Imaging Characterization
  • Abstract Number: 0193
    Articular manifestations at disease onset in ANCA-associated vasculitides: prevalence and correlation with disease phenotype and long-term outcomes
  • Abstract Number: 2897
    Artificial Intelligence (AI) Curriculum for Continuing and Graduate Medical Education: A Multi-Center Pilot
  • Abstract Number: 1897
    Artificial Intelligence for Ultrasound-Based Detection of Giant Cell Arteritis
  • Abstract Number: 0869
    Artificial Intelligence in Rheumatology: A Comparative Evaluation of Guideline Concordance and Hallucination Risk Across Platforms
  • Abstract Number: 2965
    Artificial Intelligence, Rheumatologist, or Both? A Blinded Comparative Evaluation of Responses to Patient Questions in Rheumatology
  • Abstract Number: 0121
    Aryl Hydrocarbon Receptor in Pulmonary Fibrosis
  • Abstract Number: 0380
    ASAS Health Index in Axial Spondyloarthritis: Validation and Burden Comparison Between Radiographic and Non-Radiographic Disease
  • Abstract Number: 1334
    ASCVD Risk Stratification in Psoriatic Disease: Derivation of a Real-World Analytic Cohort and Association with Incident Cardiovascular Events
  • Abstract Number: 2232
    Aspirin Exposure and Thrombosis Risk in Lupus Anticoagulant-Positive SLE Patients
  • Abstract Number: 1773
    Assessing Barriers to Recombinant Zoster Vaccination in Immunosuppressed Adults: Baseline Data and Quality Improvement Planning For an Academic Rheumatology Clinic.
  • Abstract Number: 1659
    Assessing Rates of Pneumococcal Vaccination in Patients on Immunosuppression: Baseline Data for an Academic Rheumatology Clinic’s Quality Improvement Initiative
  • Abstract Number: 1366
    Assessing the Patient Experience of Nipocalimab: Exit Interviews from the Phase 2 Randomized Placebo-Controlled Study in Sjogren’s Disease
  • Abstract Number: 2644
    Assessing the Reliability of the Ultrasound Semiquantitative Scoring System for Gout – a Patient-Based Reliability Study by the OMERACT Ultrasound Working Group
  • Abstract Number: 1118
    Assessment of activity in adults with IgA vasculitis
  • Abstract Number: 2317
    Assessment of Cardiovascular Risk Factors in Radiographic and Non-Radiographic Axial Spondyloarthritis: A Study from a Large Tertiary Care Center
  • Abstract Number: 0543
    Assessment of Evidence-Based Medicine Competency in Fourth Year Medical Students
  • Abstract Number: 2474
    Assessment of Knowledge of Rheumatoid Arthritis among Nursing professionals in an Urban Teaching Hospital Using the Rheumatoid Arthritis Knowledge Assessment Scale (RAKAS)
  • Abstract Number: 0291
    Assessment of Neurofilament Light Chain Levels in Neuropsychiatric Systemic Lupus Erythematosus
  • Abstract Number: 2825
    Assessment of Pain Characteristics and Nociplasticity in Patients with Inflammatory Myopathies: An International Survey Study
  • Abstract Number: 0921
    Assessment of Renal, Hematological, and Immunological Lab Values Among Patients Diagnosed With Systemic Lupus Erythematosus Pre- and Post-Anifrolumab Treatment Initiation: A Large Real-World Analysis
  • Abstract Number: 2944
    Assessment of Spondyloarthritis International Society Points to Consider for the Management of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis
  • Abstract Number: 0836
    Assessment of TPMT Testing and Leukopenia Risk in Patients Initiating Azathioprine in a Single-Center Rheumatology Clinic
  • Abstract Number: 1701
    Association Between Caregiver-Reported Social Risk and Clinic Adherence Rates in Pediatric Rheumatology
  • Abstract Number: 0804
    Association Between Cigarette Smoking and Autoimmune Rheumatic Diseases: Combined Real-World Cohort Study and Systematic Review/Meta-Analysis of Systemic Lupus Erythematosus
  • Abstract Number: 1527
    Association Between Clinical Manifestations of Gout and Patient Reported Outcome Measures: Results of a Real-World Survey in The United States
  • Abstract Number: 1089
    Association between Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Rheumatologic Diseases: A Population-Based Study Using UK Biobank Data
  • Abstract Number: 1150
    Association Between Daily Dose of Oral Glucocorticoids and Infections in Patients with Eosinophilic Granulomatosis with Polyangiitis Treated with Anti-Interleukin-5/Receptor Therapies
  • Abstract Number: 1429
    Association between DAS28-GGT and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
  • Abstract Number: 1736
    Association between Early Mortality in Systemic Lupus Erythematosus and Water System Per- and Polyfluoroalkyl Substances Exposure
  • Abstract Number: 2736
    Association Between Frailty and Major Adverse Cardiovascular Events in Older Adults with Rheumatoid Arthritis
  • Abstract Number: 1119
    Association Between Glucocorticoid Duration and Baseline Frailty In An Inception Cohort of Older Adults With Polymyalgia Rheumatica
  • Abstract Number: 1430
    Association Between GlycA and Vascular Inflammation in Rheumatoid Arthritis: Secondary Analysis of the TARGET Randomized Trial Comparing TNF Inhibition With Triple Therapy
  • Abstract Number: 1607
    Association Between Open Burn Pit Exposure, Multisystem Organ Involvement, and Biologic Use in Veterans with Sarcoidosis: A Single-Center Retrospective Study
  • Abstract Number: 2737
    Association Between Pharyngitis and Incident Rheumatic Disease: A Population-Based, Case-Control Study
  • Abstract Number: 0410
    Association Between Salivary Gland Power Doppler Ultrasound Findings and Disease Activity in Sjögren’s Disease
  • Abstract Number: 1608
    Association between sarcoidosis and gout: A retrospective analysis
  • Abstract Number: 2867
    Association between Sarcoidosis and Risk of Plasma Cell Dyscrasias: A Propensity-Matched Cohort Study.
  • Abstract Number: 1251
    Association Between Serum Complement Levels and Infection Risk in Systemic Lupus Erythematosus: A Longitudinal Analysis of a Nationwide Multicenter Registry
  • Abstract Number: 2167
    Association between serum type I interferon activity and domain-specific disease burden assessed by ScleroID in Systemic Sclerosis
  • Abstract Number: 1367
    Association Between Sjögren’s Disease and the Risk of Congestive Heart Failure: A Systematic Review and Meta-Analysis
  • Abstract Number: 0161
    Association Between Smoking History and Giant Cell Arteritis Development in Patients with Polymyalgia Rheumatica: A Retrospective Cohort Study
  • Abstract Number: 2701
    Association Between Social Determinants of Health and Patient-Reported Outcomes Measurement Information System Scores in Children with Rheumatic Diseases
  • Abstract Number: 1210
    Association Between Sustained Peripheral CD19+ B-Cell Depletion and Clinical Efficacy of Obinutuzumab in Lupus Nephritis: Post hoc Analyses of a Phase 3 Trial
  • Abstract Number: 2562
    Association Between Total Knee Replacement and Effusion-Synovitis in the OAI Progression Cohort and Implications for Designing Clinical Trials Addressing TKR Endpoints in Synovitis+ Populations
  • Abstract Number: 1571
    Association of 5-year Structural Progression and 12-year Pain Outcomes in Persons with Meniscal Tear and Knee OA
  • Abstract Number: 2881
    Association of an idiopathic pulmonary fibrosis polygenic risk score with rheumatoid arthritis-associated interstitial lung disease across multiple biobanks
  • Abstract Number: 2030
    Association of anti-malondialdehyde-acetaldehyde antibodies and FLI1 is enhanced by the development of RA
  • Abstract Number: 0347
    Association of Early Improvements in Back Pain With Long-Term Clinical and Patient-Reported Outcomes in Patients With Axial Spondyloarthritis Treated With Upadacitinib in a Real-World Observational Study
  • Abstract Number: 1887
    Association of genetically proxied TNF and interleukin-6 signaling with heart failure risk in two large biobanks
  • Abstract Number: 1302
    Association of GLP-1 Agonist Prescription with Improved Outcomes in Psoriatic Arthritis Patients
  • Abstract Number: 1038
    Association of GLP-1 Agonist Prescription with Joint Outcomes in Rheumatoid Arthritis
  • Abstract Number: 2153
    Association of GLP-1 Receptor Agonists with Pulmonary Hypertension, Interstitial Lung Diseases, and Major Cardiovascular Events in Systemic Sclerosis
  • Abstract Number: 0292
    Association of High Lupus Severity Index Scores and Distinct Immunogenetic Loci with Early Mortality in Systemic Lupus Erythematosus
  • Abstract Number: 0003
    Association of Increasing Genetically-Mediated Complement Activity with ANCA-Associated Vasculitis
  • Abstract Number: 1492
    Association of Markedly Elevated IL-18 With Interstitial Lung Disease and Severe Disease Phenotypes in Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 1702
    Association of Medicaid Unwinding with Access to Care for Juvenile-Onset SLE: A Single-Center Pilot Study
  • Abstract Number: 0531
    Association of Menopause and Systemic Rheumatic Disease Severity in Perimenopausal and Menopausal Women with Systemic Rheumatic Disease
  • Abstract Number: 1572
    Association of Multi-Joint Osteoarthritis Burden with Change in Physical Function Over Time
  • Abstract Number: 0475
    Association of Novel Autoantibodies With Interstitial Lung Disease and Erosive Disease in Seronegative Rheumatoid Arthritis: A Retrospective Cohort Study of Veterans
  • Abstract Number: 1737
    Association of respiratory infections with the subsequent development of rheumatoid arthritis-associated interstitial lung disease by fibrotic and non-fibrotic subtypes
  • Abstract Number: 0476
    Association of Serum Fibrinogen – Like Protein 1 with Disease Activity in Rheumatoid Arthritis: A Cross-Sectional Case-Control Study
  • Abstract Number: 1252
    Association of social measures and exercise self-efficacy with physical activity guideline adherence in adults with systemic lupus erythematosus
  • Abstract Number: 0750
    Association of Synovitis Activity Measured by Synovial Tissue Volume (STV) and Dynamic Contrast Enhanced (DCE)-MRI in Patients with Inflammatory Knee Osteoarthritis
  • Abstract Number: 0708
    Association of Time-Varying Gout Disease Activity with Incident Major Adverse Cardiovascular Events Among Patients with Newly Diagnosed Gout
  • Abstract Number: 1399
    Association of Tissue Inhibitor of Metalloproteinases 1 (TIMP1) With Therapeutic Response and Disease Activity Dynamics in Rheumatoid Arthritis Receiving Adalimumab
  • Abstract Number: 0411
    Association of Two Tear Inflammatory Biomarkers, MMP-9 and Osmolarity, with Minor Salivary Gland Biopsy Positivity and Ocular Surface Damage in Primary Sjögren’s Disease.
  • Abstract Number: 0293
    Association of Urinary Proteomic Biomarkers with Disease Activity Parameters in Patients with Systemic Lupus Erythematosus and Lupus Nephritis
  • Abstract Number: 2318
    Association of Vitamin D Levels with Disease Activity, Function, and Clinical Outcomes Over Two Years in Radiographic Axial Spondyloarthritis
  • Abstract Number: 2416
    Associations Between IgA Autoantibody Signatures, CD89 Polymorphism, and Disease Activity in Methotrexate Treated Patients with Rheumatoid Arthritis
  • Abstract Number: 1687
    Associations Between Pattern on High-Resolution Computed Tomography and Further Progression in Patients with Systemic Autoimmune Rheumatic Diseases and Progressive Pulmonary Fibrosis
  • Abstract Number: 2520
    Associations Between Social Risk Factors and Patient-Reported Outcomes in Individuals with Rheumatoid Arthritis
  • Abstract Number: 2417
    Associations of Clinical and Research Autoantibodies with Deep Learning-Derived Quantitative Measures of Interstitial Abnormalities and Emphysema on Chest Computed Tomography Imaging
  • Abstract Number: 0477
    Associations of Rheumatoid Arthritis, Chronic Lung Diseases, and Acute Respiratory Exacerbations Among Smokers in a Multicenter Prospective Study
  • Abstract Number: 2353
    Associations of salivary gland ultrasonographic findings with clinical features in primary Sjögren syndrome
  • Abstract Number: 1911
    Attendance Patterns And Associations In Rheumatology Clinics Across England. Identifying Targets To Reduce Health Disparities For People Aged 30 And Below.
  • Abstract Number: 2081
    Atypical B Cells Are Expanded in Children and Adults with Still’s Disease-Associated Lung Disease and Exhibit a Transcriptional Program of Environmental Surveillance and Inflammatory Activation
  • Abstract Number: 2913
    Atypical CD16+CD66b+ Subset is Associated with Poor Prognosis in Anti-MDA5 Dermatomyositis Associated Interstitial Lung Disease.
  • Abstract Number: 2853
    Autoantibodies against TRIM72 Protein Compromise Membrane Repair in Lupus: Evidence from Human Cardiac Tissue and Patient-Derived Organoids
  • Abstract Number: 2882
    Autoantibodies and Risk for Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease with Comparisons to Idiopathic Pulmonary Fibrosis and Healthy Controls
  • Abstract Number: 1051
    Autoantibodies and Systemic Inflammation Axes Define Subgroups in ACPA+ Individuals During Progression to Rheumatoid Arthritis
  • Abstract Number: 0143
    Autoantibodies Reveal Pathogenic Mechanisms, Diagnostic Signatures, and Therapeutic Targets in Post-COVID Syndrome with ME/CFS
  • Abstract Number: 0095
    Autoantibody levels and the development of inflammatory arthritis in a clinical trial of hydroxychloroquine for the prevention of rheumatoid arthritis
  • Abstract Number: 1832
    Autoantibody Profiling in Pre-RA: Insights from a Large Longitudinal U.S. Military Cohort
  • Abstract Number: 1981
    Autoantibody-Mediated Non-Canonical Endothelin Receptor Signaling as a Mechanism of Vascular Dysfunction in Systemic Lupus Erythematosus
  • Abstract Number: 0144
    Autoantigen-Drug Conjugates (AADCs) Selectively Target Autoreactive B Cells in Autoimmune Diseases
  • Abstract Number: 1151
    Autoimmune And Non-Autoimmune Tracheobronchial Stenosis: Comparative Clinical Features And Outcomes
  • Abstract Number: 0729
    Autoimmune Manifestations After Parvovirus B19 Infection: A Clinical Observational Study
  • Abstract Number: 0673
    Autoimmune thyroid disease associates with markers of inflammation in the Third National Health and Nutrition Examination Survey Study
  • Abstract Number: 1949
    Autoimmune-Optimized T Cell Engagers Selectively Deplete Pathogenic Immune Cell Subsets While Preserving Protective Immunity
  • Abstract Number: 2194
    Autologous BAFF Ligand CAR T Cells in Adults with Refractory Systemic Lupus Erythematosus
  • Abstract Number: 1559
    Automated L1 Vertebral Trabecular Bone Density Measurements from Computed Tomography (CT) Images are Independently Associated with Incident Fragility Fractures in Older Adults
  • Abstract Number: 1573
    Automated Synovial Mast Cell Quantification Reveals Associations with Pain, Obesity and Interferon Related Inflammation in Osteoarthritis
  • Abstract Number: 0751
    Automated Ultrasound Identification and Grading of Knee Meniscal CPPD: Interim Analysis of the OMERACT Ultrasound CPPD Subtask
  • Abstract Number: 2354
    Automatic classification of salivary gland ultrasound images in Sjögren’s disease with Deep Learning models
  • Abstract Number: 1660
    Automating Medication Monitoring in Rheumatology: Improving Efficiency While Maintaining Safety
  • Abstract Number: 1921
    Automating Rheumatoid Arthritis Trial Pre-Screening from the Electronic Health Record: A Real-World, Period-Matched Analysis
  • Abstract Number: 0931
    AvacoStar: First interim results from a prospective real-world safety study of avacopan in adults with ANCA-associated vasculitis (AAV)
  • Abstract Number: 0544
    Award-Winning Undergraduate Rheumatology Teaching Concept at the University of Pecs, Hungary
  • Abstract Number: 1528
    Awareness of orofacial manifestations of SSc among patients and clinicians in Northern Ireland: a scoping review and cross-sectional survey study
  • Abstract Number: 2319
    Axial Spondyloarthritis beyond the Spine in Latin America: One-Year Manifestation Patterns from the ESPALDA-PANLAR Registry
  • Abstract Number: 0892
    Axial Spondyloarthritis Reporting and Data System (axSpA-RADS): Guideline for Standardized Reporting of Lumbosacral MRI Examinations with Initial Validation Among Fellowship-trained Musculoskeletal readers
All • [a] b c d e f g h i j k l m n o p q r s t u v w x y z

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology